TAKEDA PHARMACEUTICAL CO LTD current holdings: USA Other Stocks
TAKEDA PHARMACEUTICAL CO LTD reported $0.00 billion in shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), 2 positions, in its Form 13F for the quarter ended 2025-09-30; the largest are Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics), Lyell Immunopharma, Inc..
- Xilio Therapeutics, Inc. (formerly Akrevia Therapeutics): Country of operation United States; Class COM; Shares 1,475,121; Value $1,243,084.
- Lyell Immunopharma, Inc.: Country of operation United States; Class COM; Shares 54,887; Value $891,365.
Form 13F-HR as filed (SEC CIK 1395064): quarter ended 2025-09-30, filed 2025-11-13. The manager files one row per sub-manager; rows for the same security, class and put/call are added together.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||